0.3701  0.037 (11.14%)		07-10 16:00
Open: 0.352 High: 0.3839 Volume: 46,372,020		Pre. Close: 0.333 Low: 0.335 Market Cap: 6(M)

Short term
Mid term
Targets	6-month :	0.49	1-year :	0.58
Resists	First :	0.42	Second :	0.49
Pivot price	0.35
Supports	First :	0.35	Second :	0.3
MAs	MA(5) :	0.34	MA(20) :	0.36
	MA(100) :	0.39	MA(250) :	0.71
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	31.9	D(3) :	21.8
RSI	RSI(14): 52.4
52-week	High :	2.59	Low :	0.23

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ SCNX ] has closed below upper band by 31.5%. Bollinger Bands are 43.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.38 - 0.39	0.39 - 0.39
Low:	0.33 - 0.33	0.33 - 0.33
Close:	0.37 - 0.37	0.37 - 0.37

As a health services IT enterprise, TRxADE HEALTH, Inc. manages an online platform designed to facilitate transactions between licensed pharmaceutical wholesalers and healthcare providers. This digital marketplace enables wholesalers to distribute a broad spectrum of products and services, encompassing branded and generic drugs as well as other non-pharmaceutical items. Customers for these offerings span government organizations, hospitals, medical clinics, and independent pharmacies. The firm's corporate base is situated in Tampa, Florida.

Fri, 10 Jul 2026
Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why - Benzinga

Thu, 09 Jul 2026
Scienture (SCNX) Prepares for Rezonopy Nasal Spray Launch - GuruFocus

Thu, 09 Jul 2026
Scienture completes manufacturing for naloxone spray launch - Investing.com UK

Thu, 09 Jul 2026
Scienture readies highest-dose naloxone spray for August sale - Stock Titan

Tue, 30 Jun 2026
Price to book forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView

Thu, 25 Jun 2026
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-than-Expected Loss Fails to Lift Shares - Earnings Trend Analysis - dars.gov.et

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	0 (M)
Shares Float	41 (M)
Held by Insiders	3.279e+007 (%)
Held by Institutions	13.3 (%)
Shares Short	1,150 (K)
Shares Short P.Month	0 (K)

EPS	-1.527e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-6 %
Return on Assets (ttm)	230.8 %
Return on Equity (ttm)	-10.9 %
Qtrly Rev. Growth	477680 %
Gross Profit (p.s.)	0.01
Sales Per Share	0.01
EBITDA (p.s.)	-0.43
Qtrly Earnings Growth	-2.5 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-13 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	23.01
Price to Cash Flow	0

Dividend	0
Forward Dividend	1.17e+006
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.